CN113621530A - Genetic engineering yeast for producing wogonin compounds, and construction method and application thereof - Google Patents

Genetic engineering yeast for producing wogonin compounds, and construction method and application thereof Download PDF

Info

Publication number
CN113621530A
CN113621530A CN202110918657.6A CN202110918657A CN113621530A CN 113621530 A CN113621530 A CN 113621530A CN 202110918657 A CN202110918657 A CN 202110918657A CN 113621530 A CN113621530 A CN 113621530A
Authority
CN
China
Prior art keywords
yeast
wogonin
genes
producing
baicalein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110918657.6A
Other languages
Chinese (zh)
Inventor
蔡孟浩
钱芷兰
陈鑫洁
赵清
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANGHAI CHENSHAN BOTANICAL GARDEN
East China University of Science and Technology
Original Assignee
SHANGHAI CHENSHAN BOTANICAL GARDEN
East China University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI CHENSHAN BOTANICAL GARDEN, East China University of Science and Technology filed Critical SHANGHAI CHENSHAN BOTANICAL GARDEN
Priority to CN202110918657.6A priority Critical patent/CN113621530A/en
Publication of CN113621530A publication Critical patent/CN113621530A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein

Abstract

The invention relates to a genetic engineering yeast for producing wogonin compounds, a construction method and application thereof. Exogenous genes are introduced into the yeast engineering bacteria through a gene recombination technology to obtain the yeast engineering bacteria capable of producing wogonin, and the wogonin compounds are produced by taking chrysin as a precursor. The yeast engineering bacteria have the characteristics of low metabolic background, strong heterologous expression capacity, capability of synthesizing end products in whole cells, easiness in separating the end products and the like, and provide a new idea for industrial production of flavonoid drugs.

Description

Genetic engineering yeast for producing wogonin compounds, and construction method and application thereof
The application is a divisional application of Chinese patent application with the application number of 202010263807.X and the application date of 2020, 4 and 7.
Technical Field
The invention belongs to the technical field of biology, and particularly relates to a genetic engineering yeast for producing wogonin compounds, a construction method and application thereof.
Background
The flavonoid compound is widely present in higher plants and ferns, belongs to a secondary metabolite of plants, and is an important active ingredient of many traditional Chinese herbal medicine plants. Flavonoids have diverse biological functions due to the particularity and diversity of their structures: treating cardiovascular and cerebrovascular system diseases, reducing blood lipid, reducing cholesterol, inhibiting thrombosis, and dilating coronary artery; improving the sensitivity of thyroid to estrogen, strengthening the function of thyroid C cells secreting calcitonin, and finally inhibiting bone resorption to treat osteoporosis; removing excessive free radicals in the metabolic process, and protecting liver cells from being damaged by electrophilic free radical compounds and poisons; inhibiting the generation of free radicals, reducing lipid peroxidation, and stimulating the action of antioxidase.
Scutellaria baicalensis Georgi (Scutellaria baicalensis Georgi) is a perennial herb of Scutellaria of Labiatae, and the root of Scutellaria baicalensis has been used as a medicine by Chinese for more than two thousand years, wherein the baicalein flavonoid molecule with the most remarkable pharmacological activity is specific to the root. The root-specific flavones are structurally different from other flavones and mainly show the deletion of 4' -OH on the B ring. Besides the traditional anti-inflammatory, antiviral and antioxidant effects, the baicalein flavonoid molecules can also play an active role in the treatment of serious diseases such as cancer, Parkinson's disease, Alzheimer's disease and the like. For example, baicalein can induce pancreatic cancer cell apoptosis by down-regulating anti-apoptotic Mcl-1 protein to achieve an anti-cancer effect, and can also inhibit the fiber formation of alpha-nucleoprotein to resist Parkinson's disease; baicalin can protect neuronal cells from oxidative stress induced by amyloid beta protein to help prevent Alzheimer's disease, and selectively block proliferation of human lung cancer cells by regulating signal molecules; wogonin can regulate the redox states of malignant tumor and normal lymphocyte to achieve the effect of distinguishing tumor cells, etc. At present, various marketed drugs contain baicalein and baicalin components, such as baicalein aluminum capsules, baicalin capsules, bear gall and scutellaria eye drops and the like.
The most common preparation method of flavonoids is directly extracting from plants by physical or chemical means. The plant extraction method is relatively direct and simple to operate, but the large consumption of plant raw materials and organic reagents can cause the method to be deeply limited by climatic and regional factors and damage human bodies and the environment. The chemical synthesis method involves violent reaction, has potential safety hazard and has limited application prospect. At present, the biological method for de novo synthesis of baicalein and other scutellaria baicalensis root specific flavones has few cases, is obviously limited by low activity of heterologous expression plant enzyme, has low flavone yield and limited promotion space, and cannot realize further industrialized application.
Prokaryotic escherichia coli has been applied to heterologous synthesis of some compounds, but the research of the inventor aiming at baicalein compounds finds that the adaptability of plant enzymes and escherichia coli is low, the expression of some plant enzymes in the escherichia coli is not ideal, and the production of the baicalein compounds in the escherichia coli is difficult by using some synthetases from scutellaria as a species source. Some of the enzymes required for the reaction are often inactive or less active when expressed in E.coli, requiring extensive expression optimisation such as the addition of fusion tags to promote correct folding, but even then often have less than optimal results. For example, production of baicalein compounds introduces enzymes of cytochrome P450 family, which are difficult to express in e.coli or must be modified in a complex way to exert partial activity. In the process of synthesizing baicalein by using the escherichia coli engineering strain, L-phenylalanine precursor is required to be manually added for synthesis, and the synthesis efficiency is low. In addition, endotoxin from E.coli potentially leads to difficulties and higher requirements for the pharmaceutical purification process.
In the prior art, although some researches are available in the aspect of expressing compounds by yeast cells, the yeast cells have not been successfully used for synthesizing baicalein compounds in the field, especially pichia pastoris cells. This may lie in that more genes need to be introduced for expressing the compounds, the catalytic activity of the protein encoded by partial genes is not high, high expression is needed to meet the requirement of synthesis capacity, and the excessive dosage of exogenous genes causes a series of physiological problems of yeast cells. For example, there is a problem of instability due to excessive foreign genes; protein folding stress adversely affects physiology; overexpression of proteins consumes carbon and energy sources of host cells and imposes a certain metabolic burden on the host. Although pichia pastoris has been applied to the expression of a large number of foreign genes, there is still a bottleneck in the art to use it for stable co-expression of a plurality of foreign genes and to achieve efficient production.
Therefore, there is a need in the art to further research and develop a novel chassis host and a production process of baicalein and other baicalein root-specific flavonoids so as to obtain high-efficiency expression, simplify the operation in the process and reduce the cost.
Disclosure of Invention
The invention aims to provide a genetic engineering yeast for producing baicalein compounds, a construction method and application thereof. The technical scheme of the invention is the only technical scheme that the whole cell can synthesize the baicalin de novo from the basic carbon source at present.
In a first aspect of the present invention, there is provided a method for producing baicalein, the method comprising: (1) providing a yeast engineering bacterium, wherein an exogenous expression cassette of the following genes is transformed in the yeast engineering bacterium: PAL, 4CL, CHS-2, CHI, FNSII-2, CPR1, F6H; and (2) culturing the yeast engineering bacteria in the step (1) to produce the baicalein.
In a second aspect of the present invention, there is provided a method for producing baicalin, the method comprising: (1) providing a yeast engineering bacterium, wherein an exogenous expression cassette of the following genes is transformed in the yeast engineering bacterium: expression cassettes for PAL, 4CL, CHS-2, CHI, FNSII-2, CPR1, F6H, UBGT; and (2) culturing the engineered yeast strain of (1) to produce baicalin.
In another aspect of the present invention, there is provided a method for producing wogonin, the method comprising: (1) providing a yeast engineering bacterium, wherein an exogenous expression cassette of the following genes is transformed in the yeast engineering bacterium: F8H, PFOMT 5; and (2) culturing the engineered yeast strain of (1), and adding chrysin as a precursor to produce wogonin.
In another preferred embodiment, the 4CL, CHS-2, CHI, FNSII-2, F6H, UBGT, F8H and PFO MT5 are derived from Scutellaria baicalensis Georgi (Sb).
In another preferred embodiment, the PAL is from Rhodotorula toruloides (Rt).
In another preferred embodiment, the CPR1 is from Arabidopsis thaliana (At).
In another preferred embodiment, the yeast engineering bacteria is pichia pastoris; preferably, when PAL, 4CL, CHS-2, CHI, FNSII-2, CPR1 and F6H are transformed in the engineered yeast, a gene fragment of PAL +4CL, a gene fragment of CHS-2+ CHI + FNSII-2 and a gene fragment of F6H + CPR1 are prepared and introduced into the engineered yeast.
In another preferred example, when the UBGT is introduced into the engineered yeast, a gene segment of UBGT + ENO1 is set; the ENO1 is a gene fragment that helps provide an integration site for UBGT. Preferably, the ENO1 can be obtained by primer amplification of the sequences of SEQ ID NO. 31 and SEQ ID NO. 32.
In another preferred embodiment, the function of KU70 gene is down-regulated or deleted in pichia pastoris.
In another preferred example, in the production of baicalein or baicalin, the culture in step (2) is carried out using a yeast culture medium, preferably supplemented with a carbon source during the culture.
In another preferred example, when baicalein or baicalin is produced, the carbon source is glucose; more preferably, glucose is added 1 time every 12 to 36 hours to a final concentration of 1 to 4% (v/v).
In another preferred embodiment, the precursor L-phenylalanine and/or malonyl-CoA is not added when baicalein or baicalin is produced.
In another preferred example, when baicalein or baicalin is produced, the culture time in the step (2) is 100-200 hours.
In another preferred embodiment, in the production of wogonin, the culture in step (2) is carried out using a yeast medium, preferably supplemented with a carbon source during the culture.
In another preferred example, when wogonin is produced, the carbon source is glucose; more preferably, glucose is added 1 time every 12 to 36 hours to a final concentration of 1 to 4% (v/v).
In another preferred example, when wogonin is produced, chrysin is added into a yeast culture medium during initial culture, and the final concentration of the fermentation liquid is 50-800 μ M; preferably 100 to 500 μ M; more preferably 150-300 μ M (e.g., 200 μ M, 250 μ M, etc.).
In another preferred embodiment, the cultivation time in step (2) is 55-95 hours when producing wogonin.
In another preferred embodiment, the production of wogonin is carried out by adding glucose 1 time every 18 to 30 hours (more preferably 22 to 26 hours) to a final concentration of 1.5 to 3% (v/v).
In another preferred embodiment, the yeast medium is a YPD medium.
In another preferred embodiment, the cultivation temperature is 30. + -. 2 ℃ and more preferably 30. + -. 1 ℃.
In another preferred embodiment, the rotation speed during the cultivation is 200. + -.50 r/min, more preferably 200. + -.20 r/min.
In another preferred embodiment, the cultivation time in step (2) is 120-180 hours, preferably 130-160 hours, such as 140, 144, 150, 155 hours, when producing baicalein or baicalin.
In another preferred embodiment, the cultivation time in step (2) is 60-90 hours, preferably 65-80 hours, such as 70, 72, 75, 80 hours, when producing wogonin.
In another preferred embodiment, the PAL gene has the nucleotide sequence shown in SEQ ID NO. 1, or a degenerate sequence thereof, or a nucleotide sequence encoding an homologous functional protein which is identical to the nucleotide sequence shown in SEQ ID NO. 1 by more than 70% (preferably more than 80%, more preferably more than 90%, more preferably more than 93%, more preferably more than 95%, more preferably more than 97%).
In another preferred embodiment, the 4CL gene has the nucleotide sequence shown in SEQ ID NO. 2, or a degenerate sequence thereof, or a nucleotide sequence encoding an isofunctional protein which is 70% or more (preferably 80% or more, more preferably 90% or more, more preferably 93% or more, more preferably 95% or more, and more preferably 97% or more) identical to the sequence shown in SEQ ID NO. 2.
In another preferred embodiment, the CHS-2 gene has the nucleotide sequence shown in SEQ ID NO. 3, or a degenerate sequence thereof, or a nucleotide sequence encoding a functional homologue having a homology of 70% or more (preferably 80% or more, more preferably 90% or more, more preferably 93% or more, more preferably 95% or more, more preferably 97% or more) to the sequence shown in SEQ ID NO. 3.
In another preferred embodiment, the CHI gene has the nucleotide sequence shown in SEQ ID NO. 4, or a degenerate sequence thereof, or a nucleotide sequence encoding an isofunctional protein which is identical to the nucleotide sequence shown in SEQ ID NO. 4 by more than 70% (preferably more than 80%, more preferably more than 90%, more preferably more than 93%, more preferably more than 95%, more preferably more than 97%).
In another preferred embodiment, the FNSII-2 gene has the nucleotide sequence shown in SEQ ID NO:5, or a degenerate sequence thereof, or a nucleotide sequence encoding an isofunctional protein which is 70% or more (preferably 80% or more; more preferably 90% or more; more preferably 93% or more; more preferably 95% or more; more preferably 97% or more) identical to the sequence shown in SEQ ID NO: 5.
In another preferred embodiment, the F6H gene has the nucleotide sequence shown in SEQ ID NO. 6, or a degenerate sequence thereof, or a nucleotide sequence encoding an isofunctional protein which is 70% or more (preferably 80% or more; more preferably 90% or more; more preferably 93% or more; more preferably 95% or more; more preferably 97% or more) identical to the sequence shown in SEQ ID NO. 6.
In another preferred embodiment, the CPR1 gene has the nucleotide sequence shown in SEQ ID NO. 7, or a degenerate sequence thereof, or a nucleotide sequence encoding an isofunctional protein which is identical to the nucleotide sequence shown in SEQ ID NO. 7 by more than 70% (preferably more than 80%, more preferably more than 90%, more preferably more than 93%, more preferably more than 95%, more preferably more than 97%).
In another preferred embodiment, the UBGT gene has the nucleotide sequence shown in SEQ ID NO. 8, or a degenerate sequence thereof, or a nucleotide sequence encoding an isofunctional protein which is 70% or more (preferably 80% or more, more preferably 90% or more, more preferably 93% or more, more preferably 95% or more, more preferably 97% or more) identical to the sequence shown in SEQ ID NO. 8.
In another preferred embodiment, the F8H gene has the nucleotide sequence shown in SEQ ID NO. 9, or a degenerate sequence thereof, or a nucleotide sequence encoding an isofunctional protein which is 70% or more (preferably 80% or more; more preferably 90% or more; more preferably 93% or more; more preferably 95% or more; more preferably 97% or more) identical to the sequence shown in SEQ ID NO. 9.
In another preferred embodiment, the PFOMT5 gene has the nucleotide sequence shown in SEQ ID NO:10, or a degenerate sequence thereof, or a nucleotide sequence encoding a functional homologue having a homology of 70% or more (preferably 80% or more, more preferably 90% or more, more preferably 93% or more, more preferably 95% or more, more preferably 97% or more) to the sequence shown in SEQ ID NO: 10.
In another preferred embodiment, the pichia pastoris is GS 115.
In another aspect of the present invention, there is provided a yeast engineering bacterium for producing baicalein, comprising an exogenous expression cassette of the following genes: PAL, 4CL, CHS-2, CHI, FNSII-2, CPR1, F6H.
In another aspect of the present invention, there is provided a yeast engineering bacterium for producing baicalin, which comprises an exogenous expression cassette of the following genes: PAL, 4CL, CHS-2, CHI, FNSII-2, CPR1, F6H. Optionally also an expression cassette for UBGT.
In another aspect of the present invention, there is provided a yeast engineering bacterium for producing wogonin, comprising an exogenous expression cassette for the following genes: F8H, PFOMT 5.
In another preferred embodiment, the yeast engineering bacteria is pichia pastoris.
In another preferred embodiment, the 4CL, CHS-2, CHI, FNSII-2, F6H, UBGT is from Scutellaria baicalensis.
In another preferred example, the F8H and PFO MT5 are from scutellaria baicalensis.
In another preferred embodiment, the PAL is from Rhodotorula toruloides.
In another preferred embodiment, the CPR1 is from arabidopsis thaliana.
In another aspect of the invention, there is provided the use of a combination of genes comprising the following groups of genes: PAL, 4CL, CHS-2, CHI, FNSII-2, CPR1 and F6H, and optionally UBGT, F8H and/or PFO MT5, which are used for transforming into yeast engineering bacteria to prepare baicalein compounds.
In another preferred embodiment, the combination of genes is placed in one or more expression constructs. For example, the gene fragment of PAL +4CL, the gene fragment of CHS-2+ CHI + FNSII-2, the gene fragment of F6H + CPR1 are placed in separate constructs.
In another preferred embodiment, the genome combination is PAL, 4CL, CHS-2, CHI, FNSII-2, CPR1 and F6H, and the baicalein compound is baicalein.
In another preferred embodiment, the combination of genes is PAL, 4CL, CHS-2, CHI, FNSII-2, CPR1, F6H and UBGT, and the baicalein compound is baicalin.
In another preferred embodiment, the genome is F8H and PFO MT5, and the baicalein compound is wogonin.
In another preferred embodiment, the 4CL, CHS-2, CHI, FNSII-2, F6H, UBGT, F8H and/or PFOMT5 is from Scutellaria baicalensis, the PAL is from Rhodotorula toruloides, and/or the CPR1 is from Arabidopsis thaliana.
In another aspect of the present invention, there is provided a kit for producing baicalein, comprising: PAL, 4CL, CHS-2, CHI, FNSII-2, F6H and CPR1 genes or expression constructs (including expression plasmids) containing said genes or yeast cells; or wherein it comprises: PAL, 4CL, CHS-2, CHI, FNSII-2, F6H, CPR1 and UBGT genes or expression constructs (including expression plasmids) containing the same or yeast cells; or wherein it comprises: F8H and PFOMT5 genes or expression constructs (including expression plasmids) or yeast cells containing said genes; preferably, the 4CL, CHS-2, CHI, FNSII-2, F6H, UBGT, F8H and/or PFOMT5 are from Scutellaria baicalensis, the PAL is from Rhodotorula toruloides, and/or the CPR1 is from Arabidopsis thaliana.
In another aspect of the present invention, there is provided a recombinant expression vector or expression construct for the production of baicalein, said recombinant expression vector comprising expression cassettes for the following genes: RtPAL, Sb4CL, SbCHS-2, SbCHI, SbFNSII-2, SbF6H, AtCPR 1.
In another aspect of the present invention, there is provided a recombinant expression vector or expression construct for producing baicalin, said recombinant expression vector comprising expression cassettes for the following genes: RtPAL, Sb4CL, SbCHS-2, SbCHI, SbFNSII-2, SbF6H, AtCPR1, SbUBGT;
in another aspect of the present invention, there is provided a recombinant expression vector or expression construct for the production of wogonin, said recombinant expression vector comprising an expression cassette for: F8H and PFOMT 5.
Other aspects of the invention will be apparent to those skilled in the art in view of the disclosure herein.
Drawings
FIG. 1 shows the synthesis of baicalein, baicalin and wogonin.
FIG. 2 shows the fermentation of strains producing baicalein, baicalin and wogonin in shake flasks.
A. The shaking flask fermentation process of recombinant strains for producing baicalein records the cell biomass and baicalein yield which change along with the fermentation time.
B. The shaking flask fermentation process of recombinant strains for producing baicalin records the cell biomass and baicalin yield which change along with the fermentation time.
C. The shake flask fermentation process of the recombinant strain producing wogonin records the cell biomass and wogonin yield as a function of fermentation time.
Detailed Description
The inventor conducts intensive research, introduces a series of exogenous genes into a yeast engineering strain (preferably pichia pastoris) through a gene recombination technology, and obtains the yeast engineering strain capable of producing baicalein, baicalin and wogonin. The yeast engineering bacteria have the characteristics of low metabolic background, strong heterologous expression capacity, no need of adding a precursor, whole-cell synthesis of a final product, easy separation of the final product and the like, and provide a new idea for industrial production of flavonoid drugs.
The invention provides a gene engineering yeast for producing baicalein compounds. By heterologous expression in engineered yeast strains of the following enzymes: phenylalanine ammonia lyase (Pal), P-coumaroyl-coa ligase (4CL), chalcone synthase (CHS-2), chalcone isomerase (CHI), flavone synthase (FNSII-2), flavone 6-hydroxylase (F6H), cytochrome P450 reductase (CPR1), which enables the de novo synthesis of baicalein in yeast cells. Furthermore, the integration of baicalein 7-O-glucosyltransferase (UBGT) on the basis of the strain can realize the de novo synthesis of baicalin in yeast cells. The intermediate product chrysin in the synthesis process of baicalein is used as a substrate. The present invention also realizes the synthesis of wogonin from chrysin in yeast cells by heterologous expression of flavone 8-hydroxylase (F8H), baicalein phenylpropanoids and flavonoid O-methyltransferase (PFOMT 5). The synthetic route constructed in the present invention is shown in FIG. 1.
The invention realizes that the microorganism utilizes the basic carbon source to synthesize the baicalein and the baicalin from the beginning for the first time, and the microorganism utilizes the chrysin to synthesize the wogonin for the first time. The recombinant yeast engineering bacteria constructed in the invention has good adaptability with plant enzymes, has unique advantages compared with prokaryotic escherichia coli in heterologous expression of plant-derived flavone synthetase, can obtain good expression and exert catalytic activity without modifying enzyme structure, and has development and application potentials.
Term(s) for
As used herein, the term "expression cassette" or "gene expression cassette" refers to a gene expression system that contains all the necessary elements required for expression of a polypeptide of interest, typically including the following elements: a promoter, a gene sequence encoding a polypeptide, a terminator; in addition, the protein also can selectively comprise a signal peptide coding sequence and the like; these elements are operatively connected.
As used herein, the term "operably linked" or "operably linked" refers to a functional spatial arrangement of two or more nucleic acid regions or nucleic acid sequences. For example: the promoter region is placed in a specific position relative to the nucleic acid sequence of the gene of interest such that transcription of the nucleic acid sequence is directed by the promoter region, whereby the promoter region is "operably linked" to the nucleic acid sequence.
As used herein, the term "expression construct" or "expression construct" refers to a recombinant DNA molecule comprising a desired nucleic acid coding sequence, which may comprise one or more gene expression cassettes. The "construct" is typically contained in an expression vector.
As used herein, the term "exogenous" or "heterologous" refers to the relationship between two or more nucleic acids or protein sequences from different sources, or the relationship between a protein (or nucleic acid) from a different source and a host cell. For example, a nucleic acid is exogenous to a host cell if the combination of the nucleic acid and the host cell is not normally naturally occurring. A particular sequence is "foreign" to the cell or organism into which it is inserted.
As used herein, the term "baicalein compound" includes baicalein, baicalin, or wogonin. The "baicalein compound" can also be a variation on the compounds disclosed herein, for example, the parent nuclear structure of the compound remains unchanged, but substitution of groups (e.g., aliphatic hydrocarbon groups containing 1 to 4 carbon atoms, preferably 1 to 2 carbon atoms) occurs at individual (e.g., 1 to 3, 1 to 2) positions.
Gene and expression system thereof
In the invention, the high-efficiency production of baicalein or baicalin in the yeast engineering bacteria is realized by transforming seven gene combinations (PAL, 4CL, CHS-2, CHI, FNSII-2, CPR1, F6H) or eight gene combinations (PAL, 4CL, CHS-2, CHI, FNSII-2, CPR1, F6H, UBGT) into the yeast engineering bacteria. In a preferred embodiment of the present invention, the seven-gene combination comprises the following genes: RtPAL, Sb4CL, SbCHS-2, SbCHI, SbFNSII-2, SbF6H, AtCPR 1; the eight-gene combination comprises the following genes: RtPAL, Sb4CL, SbCHS-2, SbCHI, SbFNSII-2, SbF6H, AtCPR1, SbUBGT. The present inventors succeeded in co-expressing these genes in yeast cells and producing compounds with high activity, since the genes of the species Scutellaria baicalensis except for RtPAL and AtCPR1 are derived from the above genes.
In the invention, the high-efficiency production of wogonin in the yeast engineering bacteria is realized by transforming two gene combinations (F8H, PFO MT5) into the yeast engineering bacteria. The two gene combinations comprise the following genes: SbF8H, SbPFOMT 5.
The gene of the present invention may be naturally occurring, for example, it may be isolated or purified from a plant or microorganism. In addition, the gene can also be artificially prepared, for example, the gene can be obtained according to the conventional genetic engineering recombination technology, or the gene can be obtained by an artificial synthesis method.
The nucleotide sequence of the gene can be the same as the sequence shown in SEQ ID NO. 1-10, or can be a degenerate variant thereof. As used herein, "degenerate variant" refers to a nucleic acid sequence that encodes a protein with identical function, but differs from a sequence selected from the group consisting of those shown in SEQ ID NOs: 1-10. The present invention includes the natural sequences of the above genes, and also includes sequences subjected to codon optimization. In the invention, the natural gene sequence is adopted for recombinant expression at present, and the yield can be expected to be further improved by optimizing by using a plurality of codon optimization methods known in the field and establishing optimized engineered yeast. These further optimization techniques based on the solution of the present invention should also be covered in the solution of the present invention.
The genes may include: a coding sequence encoding only the mature polypeptide; the coding sequence for the mature polypeptide and various additional coding sequences; the coding sequence (and optionally additional coding sequences) as well as non-coding sequences for the mature polypeptide.
The invention also relates to variants of said genes, which encode polypeptides which differ in amino acid sequence from their corresponding wild-type polypeptide, being fragments, analogues or derivatives of the wild-type polypeptide. The variant of the polynucleotide may be a naturally occurring allelic variant or a non-naturally occurring variant. These nucleotide variants include substitution variants, deletion variants and insertion variants. As is known in the art, an allelic variant is a substitution of a polynucleotide, which may be a substitution, deletion, or insertion of one or more nucleotides, without substantially altering the function of the polypeptide encoded thereby.
The present invention also relates to polynucleotides which hybridize to the sequences described above and which have at least 50%, preferably at least 70%, and more preferably at least 80% identity between the two sequences. The present invention particularly relates to polynucleotides which hybridize under stringent conditions to the polynucleotides of the present invention. In the present invention, "stringent conditions" mean: (1) hybridization and elution at lower ionic strength and higher temperature, such as 0.2 XSSC, 0.1% SDS, 60 ℃; or (2) adding denaturant during hybridization, such as 50% (v/v) formamide, 0.1% calf serum/0.1% Ficoll, 42 deg.C, etc.; or (3) hybridization occurs only when the identity between two sequences is at least 90% or more, preferably 95% or more. Also, the polynucleotides that hybridize to the polypeptide encoded by the polynucleotide have the same biological functions and activities as the corresponding wild-type polypeptide.
Each gene of the present invention is preferably obtained from Rhodotorula toruloides, Scutellaria baicalensis, and Arabidopsis thaliana. The present invention may also include other genes obtained from other microorganisms that are highly homologous (e.g., have greater than 70%, such as 80%, 90%, 95%, or even 98% sequence identity) to the corresponding genes in Rhodotorula toruloides, Scutellaria baicalensis, and Arabidopsis thaliana, and are also contemplated within the scope of the present invention. Methods and means for aligning sequence identity are also well known in the art, for example BLAST.
The full-length sequence of each gene of the present invention or a fragment thereof can be obtained by a PCR amplification method, a recombination method, or an artificial synthesis method. For PCR amplification, primers can be designed based on the nucleotide sequences disclosed herein, particularly the open reading frame sequences, and the sequences can be amplified. When the sequence is longer, two or more PCR amplifications can be carried out, and then the amplified fragments are spliced together according to the correct sequence.
The invention also relates to a vector comprising said polynucleotide, and a host cell genetically engineered with said vector.
In the present invention, the sequence of each gene may be inserted into a recombinant expression vector. The term "recombinant expression vector" refers to a bacterial plasmid, bacteriophage, yeast plasmid, plant cell virus, mammalian cell virus, or other vector well known in the art. In general, any plasmid or vector can be used as long as it can replicate and is stable in the host. An important feature of expression vectors is that they generally contain an origin of replication, a promoter, a marker gene and translation control elements.
The sequences of the genes can be respectively inserted into recombinant expression vectors, and a plurality of the recombinant expression vectors are co-transferred into host cells; the expression cassettes of multiple genes can also be inserted into the same recombinant expression vector in tandem and transferred into host cells. The recombinant expression vector may further comprise an expression control sequence operably linked to the sequence of the gene to facilitate expression of the protein. It is understood that recombinant expression vectors can be conveniently constructed by those skilled in the art having the benefit of the teachings of the present invention. The obtained recombinant expression vector is also included in the present invention.
In the expression regulation sequence or the expression cassette, an inducible or constitutive promoter can be applied according to different requirements, and the inducible promoter can realize more controllable protein expression and compound production, thereby being beneficial to industrial application.
As a preferred mode of the present invention, there is provided an expression vector (expression construct) comprising an expression cassette of the following genes: RtPAL, Sb4CL, SbCHS-2, SbCHI, SbFNSII-2, SbF6H, AtCPR 1; there is also provided another expression vector (expression construct) comprising an expression cassette for the following genes: SbUBGT; and another expression vector (expression construct) comprising an expression cassette for the following genes: SbF8H, SbPFOMT 5.
The expression vector (expression construct) can be established using techniques familiar to those skilled in the art. Once the desired selected gene is known, one skilled in the art can proceed to create an expression construct. The gene sequences may be inserted into different expression constructs (e.g., expression vectors) or into the same expression construct, so long as the encoded polypeptide is efficiently expressed and active after transfer into a cell. In a preferred embodiment of the present invention, the expression vector is pGAP Z α.
Vectors containing the appropriate gene sequences and appropriate promoter or control sequences described above may be used to transform appropriate host cells to enable expression of the protein. In the invention, the host cell is preferably a yeast engineering bacterium, more preferably pichia pastoris, such as pichia pastoris GS 115.
Transformation of a host cell with recombinant DNA can be carried out using conventional techniques well known to those skilled in the art. When the host is a eukaryote, the following DNA transformation methods can be used: calcium phosphate coprecipitation, conventional mechanical methods such as microinjection, electroporation, liposome encapsulation, etc.
The obtained transformant can be cultured by a conventional method, and the medium used in the culture can be a yeast medium well known in the art. The culture is performed under conditions suitable for growth of the yeast cells.
The present invention also provides a kit for biosynthesizing a baicalein compound, which comprises: PAL, 4CL, CHS-2, CHI, FNSII-2, F6H and CPR1 genes or expression constructs (including expression plasmids) containing said genes or yeast cells; or comprises the following steps: PAL, 4CL, CHS-2, CHI, FNSII-2, F6H, CPR1 and UBGT genes or expression constructs (including expression plasmids) containing the same or yeast cells; or comprises the following steps: F8H and PFOMT5 genes or expression constructs (including expression plasmids) or yeast cells containing the genes. More preferably, the kit further comprises instructions for performing the biosynthetic method.
The recombinant pichia pastoris strain obtained by the gene recombination technology has the characteristics of low metabolic background, strong heterologous expression capability, no need of adding a precursor additionally, capability of synthesizing a final product in a whole cell manner, easiness in separation of the final product and the like, solves the problems in the synthesis by the traditional biological and chemical methods to a great extent, and provides a new idea for industrially producing flavonoid drugs. Particularly, the invention realizes the successful expression of various genes from the scutellaria in the yeast engineering bacteria, which is closer to the natural processing mode of the baicalein in plants, and ensures the high-efficiency production of the baicalein compounds.
Method for synthesizing baicalein, baicalin and wogonin
The structural formula of baicalein is shown in the following formula (I), the structural formula of baicalin is shown in the following formula (II), and the structural formula of wogonin is shown in the following formula (III).
Figure BDA0003206623420000111
The invention discloses a method for producing baicalein, baicalin and wogonin by microbial heterologous synthesis. The method comprises the following steps: transforming seven genes (preferably RtPAL, Sb4CL, SbCHS-2, SbCHI, SbFNSII-2, SbF6H, AtCPR1) into engineering yeast bacteria to produce baicalein; alternatively, eight genes (preferably RtPAL, Sb4CL, SbCHS-2, SbCHI, SbFNSII-2, SbF6H, AtCPR1, SbUBGT) are transformed into the yeast engineering bacteria to produce baicalin; alternatively, wogonin is produced by transforming a yeast engineering bacterium with two genes (preferably SbF8H, SbPFOMT 5).
The invention also provides a fermentation culture method of the recombinant yeast engineering bacteria for producing the baicalein or the baicalin. The yeast engineering bacteria for producing baicalein or baicalin can be cultured by using a yeast culture medium, and a carbon source is preferably supplemented during the culture; preferably the carbon source is glucose; preferably, 1 time of glucose is added every 12 to 36 hours; more preferably to a final concentration of 1-4% (v/v). Particularly, when the recombinant yeast engineering bacteria are produced, the enzyme activity is ideal and the endogenous mechanism of yeast cells is mobilized, so the technical scheme of the invention can produce the baicalein compounds on the basis of not adding precursors of L-phenylalanine and/or malonyl coenzyme A; this is advantageous for large-scale production, and simplifies the process (e.g., the preparation of the culture medium is simpler and clearer, and the separation and purification of the product at the later stage are more convenient), and reduces the cost. In a preferred embodiment of the present invention, the culture time is optimized to be 100-200 hours, preferably 120-180 hours, and more preferably 130-160 hours according to the production characteristics of the recombinant yeast engineering bacteria for producing baicalein or baicalin.
In one embodiment of the present invention, a preferred method for producing baicalein or baicalin is provided, comprising: culturing the recombinant strain in liquid YPD culture at 30 deg.C and 200r/min to logarithmic phase, collecting thallus, washing with sterile water twice, transferring to YPD culture medium, and culturing at 30 deg.C and 200r/min for 144 h. 2% glucose was added to the broth every 24h during fermentation.
The invention also provides a fermentation culture method of the recombinant yeast engineering bacteria for producing wogonin. The yeast engineering bacteria for producing wogonin can be cultured by using a yeast culture medium, and a carbon source is preferably supplemented during the culture; preferably the carbon source is glucose; preferably, 1 time of glucose is added every 12 to 36 hours; more preferably to a final concentration of 1-4% (v/v). In a preferred embodiment of the present invention, the present inventors have optimized the culture time to be 55-95 hours, preferably 60-90 hours, more preferably 65-80 hours according to the production characteristics of the recombinant engineered yeast strain for producing wogonin.
In one embodiment of the present invention, a preferred method for producing wogonin is provided, comprising: culturing the recombinant strain in liquid YPD culture at 30 deg.C and 200r/min to logarithmic phase, collecting thallus, washing with sterile water twice, transferring to YPD culture medium, adding 200 μ M chrysin as precursor, and culturing at 30 deg.C and 200r/min for 72 h. 2% glucose was added to the broth every 24h during fermentation.
After obtaining the fermentation product, extracting baicalein, baicalin, or wogonin from the fermentation product may employ techniques known in the present invention. The product can be analytically identified using high performance liquid chromatography to confirm that the desired compound is obtained.
The invention has the main advantages that:
the invention uses recombinant pichia pastoris for heterologous production of baicalein, thereby solving the problems that a plant extraction method consumes a large amount of plant raw materials, is limited by seasonal regional factors, has low extraction efficiency and the like; adverse factors such as more byproducts, low activity of target products, large environmental pollution and the like in the chemical synthesis method are avoided; compared with the method of using escherichia coli as a chassis host, the method solves the problem of low heterologous expression activity of plant enzymes, is more suitable for efficient synthesis of flavonoids such as baicalein and the like, and opens up a new way for industrial production of flavonoids such as baicalein and the like. Therefore, the recombinant pichia pastoris strain has the potential of industrial production of baicalein.
The invention realizes the technical breakthrough of using the recombinant yeast to carry out whole-cell de novo biosynthesis of the baicalein and the baicalin, and the basic carbon source can meet the production requirement without adding an amino acid precursor, thereby providing a new way for producing the baicalein and other flavonoid compounds.
The invention will be further illustrated with reference to the following specific examples. It should be understood that these examples are for illustrative purposes only and are not intended to limit the scope of the present invention. The experimental procedures, for which specific conditions are not noted in the following examples, are generally performed according to conventional conditions such as those described in J. SammBruk et al, molecular cloning protocols, third edition, scientific Press, 2002, or according to the manufacturer's recommendations.
Culture medium
YPD liquid medium: 20.0g/L of glucose, 20.0g/L of peptone and 10.0g/L of yeast extract;
YPD solid Medium: 20.0g/L of glucose, 20.0g/L of peptone, 10.0g/L of yeast extract and 20.0g/L of agar;
YND solid Medium: 20.0g/L glucose, 6.7g/L nitrogen source (YNB) without amino yeast and 20.0g/L agar;
example 1 construction of expression plasmid
1、PGAPConstruction of plasmids expressing respective genes
The genes RtPAL, AtCPR1 and SbUBGT are composed of threonineThe national jingzhi biotechnology limited was synthesized and constructed directly on the vector plasmid pGAP Z α (Invitrogen), plasmid name: pGAP _ RtPal, pGAP _ AtCPR1pGAP _ SbUBGT. The original plasmids for the other genes (Sb4CL, SbCHS-2, SbCHI, SbFNSII-2, SbF6H, SbF8H, SbPFOMT5) were obtained from the Shanghai research center for plant science, Zhongkobai. Designing specific primers, and carrying out PCR amplification by using original plasmids of all genes as templates and using corresponding primers in table 1 to obtain related genes (Sb4CL, SbCHS-2, SbCHI, SbFNSII-2, SbF6H, SbF8H and SbPFOA 5) derived from scutellaria baicalensis; using AsuII and KpnI to double-enzyme cut the plasmid pGAP Z alpha, adopting a seamless assembly kit to integrate each gene into the P in the plasmid pGAP Z alpha respectivelyGAPDownstream, sequencing correctly to obtain a DNA fragment having PGAPPlasmid expressing each gene, plasmid name: pGAP _ Sb4CL, pGAP _ SbCHS-2, pGAP _ SbCHI, pGAP _ SbFNSII-2, pGAP _ SbF6H, pGAP _ SbF8H, pGAP _ SbPFOMT 5.
Wherein the gene sequence of the RtPAL is shown as SEQ ID NO. 1;
the gene sequence of Sb4CL is shown as SEQ ID NO. 2;
the gene sequence of SbCHS-2 is shown as SEQ ID NO. 3;
the gene sequence of SbCHI is shown in SEQ ID NO. 4;
the gene sequence of SbFNSII-2 is shown as SEQ ID NO. 5;
the gene sequence of SbF6H is shown in SEQ ID NO. 6.
The gene sequence of AtCPR1 is shown in SEQ ID NO. 7.
The gene sequence of SbUBGT is shown as SEQ ID NO. 8;
the gene sequence of SbF8H is shown as SEQ ID NO. 9;
the gene sequence of SbPFOMT5 is shown in SEQ ID NO: 10.
The primers used for PCR amplification are shown in Table 1.
TABLE 1
Figure BDA0003206623420000131
2. Construction of Gene-Combined plasmid
The plasmids pGAP _ RtpAl, pGAP _ SbFNSII-2, pGAP _ SbF6H and pGAP _ SbF8H constructed in the above "1" were digested with BamH I, and the linearized plasmids were recovered, respectively.
The plasmids pGAP _ Sb4CL, pGAP _ SbCHI, pGAP _ AtCPR1 and pGAP _ SbPFMT 5 constructed in the above "1" were used as templates, and BamH I in Table 1 was used as primers to obtain complete expression cassettes of Sb4CL, SbCHI, AtCPR1 and SbPFMT 5 genes including promoters and terminators by PCR amplification and recovery. Linearized plasmids and gene expression cassettes can be ligated by means of a seamless assembly kit to give plasmids pGAP _ Rtpal + Sb4CL, pGAP _ SbCHI + SbFNSII-2, pGAP _ SbF6H + AtCPR1, pGAP _ SbF8H + SbPFOMT 5.
BtgZ I is used for enzyme digestion of the plasmid pGAP _ SbCHI + SbFNSII-2, and the linearized plasmid is recovered. The plasmid pGAP _ SbCHS-2 constructed in the above "1" was used as a template, BtgZ I in Table 1 was used as a primer, and the complete expression cassette of SbCHS-2 gene including a promoter and a terminator was recovered by PCR amplification. The linearized plasmid and the expression cassette of the gene can be connected by a seamless assembly kit to obtain the plasmid pGAP _ SbCHS-2+ SbCHI + SbFNSII-2.
3. Construction of Gene-Combined plasmid containing homology arm
Linearized plasmids were recovered using ApaI and XhoI double digestion of plasmids pDAG2, pDTg1 and pDFg1 (see Liu Q, Shi X, Song L, et al. CRISPR-Cas 9 mediated genomic polymorphism in Pichia pastoris [ J ]. Microbiological Cell Factories,2019,18: 144). The plasmids pGAP _ RtPal + Sb4CL, pGAP _ SbCHS-2+ SbCHI + SbFNSII-2, pGAP _ SbF6H + AtCPR1 and pGAP _ SbF8H + SbPFOMT5 constructed in the above "2" were used as templates, and ApaI to SpeI in Table 1 were used as primers to amplify by PCR to obtain fragments containing a plurality of gene expression cassettes, and the linearized plasmids and the expression cassette fragments of the genes were ligated by means of a seamless assembly kit to obtain plasmids pDAG2_ RtPal + Sb4CL, pDTg1_ SbCHS-2+ SbCHI + SbFNSII-2, pDFg1_ SbF6H + AtCPR1, and pDAG2_ SbF8H + SbPFO 5.
4. Construction of plasmid containing ENO1 integration site
The plasmid pGAP _ SbUBGT constructed in the above "1" was digested with Nsi I, and the linearized plasmid was recovered. The genome of Pichia pastoris GS115 is used as a template, ENO1 fragments are amplified by corresponding primers in the table 1, and linearized plasmids and ENO1 fragments can be connected by a seamless assembly kit to obtain plasmids pGAP _ SbUBGT + ENO 1.
Example 2 preparation of target recombinant Yeast
1. PCR validation of recombinant strains
Electrically transforming each DNA fragment and the corresponding gRNA plasmid into pichia pastoris GS 115-delta ku70 (see 201910403132.1), recovering, coating on an YND solid culture medium, culturing for 5 days, selecting a fresh bacterial colony to culture in a YPD liquid culture medium, extracting the genome of each transformant by using a yeast genome extraction kit, and identifying the condition that each gene synthesized by baicalein is integrated into the pichia pastoris genome through cloning PCR reaction.
Cloning PCR reaction conditions:
(1) initial denaturation at 95 ℃ for 5 min;
(2) denaturation at 95 ℃ for 30s, annealing at 50 ℃ for 30s, extension at 72 ℃ for 1min/kb, and circulating reaction for 30 times;
(3) finally, the extension is carried out for 7min at 72 ℃.
2. Obtaining of recombinant bacteria containing 7 exogenous genes
Specific primers were designed, and the plasmids pDAG2_ RtPal + Sb4CL, pDTG1_ SbCHS-2+ SbCHI + SbFNSII-2 and pDFg1_ SbF6H + AtCPR1 were used as templates, and the corresponding primers in Table 2 were used to obtain each gene fragment containing the homologous arm by PCR amplification, and were electrically transformed into Pichia pastoris competence with the circular plasmid 3.5k-PFg1-PAg2+ pTg1 (see Liu Q, Shi X, Song L, et al. CRISPR-Cas 9 mediated genomic polymorphism in Pichia pastoris [ J ]. Microbiological Cell Factories,2019,18:144), and the recombinant was screened by YND solid culture to obtain Pichia pastoris engineered yeast transformed with 7 foreign genes (SbRtPAL, Sb4CL, CHS-2, CHI, SbFNI-4832, SbF6, SbCPR) 1. The strain was streaked onto YPD solid medium and PCR validation of the recombinant strain was performed again to ensure loss of the circular plasmid.
TABLE 2
Figure BDA0003206623420000151
3. Obtaining of recombinant bacteria containing 8 exogenous genes
The recombinant yeast containing 7 exogenous genes obtained in the above 2 was made competent, and the linearized plasmid pGAP _ SbUBGT + ENO1 was electrically transformed into the competent state, and recombinants were selected using a solid YPD medium having bleomycin resistance, to obtain Pichia pastoris genetically engineered bacteria into which 8 exogenous genes (RtPAL, Sb4CL, SbCHS-2, SbCHI, SbFNSII-2, SbF6H, AtCPR1, SbUBGT) were transferred.
4. Obtaining of recombinant bacteria containing 2 exogenous genes
Specific primers are designed, plasmid pDAG2_ SbF8H + SbPFOMT5 is used as a template, corresponding primers in table 2 are used for PCR amplification to obtain each gene fragment containing a homology arm, the gene fragment and a circular plasmid 3.5k-PAg2 (see Liu Q, Shi X, Song L, et al. CRISPR-Cas 9 mediated genomic integration in Pichia pastoris [ J ]. Microbiological Cell Factories,2019,18:144) are simultaneously electrically transformed into a Pichia pastoris competence, YND solid culture is used for screening recombinants, and Pichia pastoris genetically engineered bacteria transformed into 2 exogenous genes (SbF8H, SbPFOMT5) are obtained. The strain was streaked onto YPD solid medium and PCR validation of the recombinant strain was performed again to ensure loss of the circular plasmid.
Example 3 fermentation Process of 250ml Erlenmeyer flask of recombinant engineering bacteria
The bacterial strain for producing the baicalein: it contains 7 kinds of exogenous genes: RtPAL, Sb4CL, SbCHS-2, SbCHI, SbFNSII-2, SbF6H, AtCPR 1.
The strains for producing baicalin: it contains 8 kinds of exogenous genes: RtPAL, Sb4CL, SbCHS-2, SbCHI, SbFNSII-2, SbF6H, AtCPR1, SbUBGT.
Strain for producing wogonin: it contains 2 kinds of exogenous genes: SbF8H, SbPFOMT 5.
The recombinant strain was cultured in a liquid YPD medium at 30 ℃ and 200r/min until logarithmic phase, the collected strain was washed twice with sterile water and transferred to a 250mL Erlenmeyer flask containing 50mL of YPD liquid medium (no precursor was added to the strain producing baicalein or baicalin, 200. mu.M chrysin was added to the strain producing wogonin, and the strain producing baicalein or baicalin was cultured at 30 ℃ and 200r/min (144 hours for the strain producing baicalein or baicalin and 72 hours for the strain producing wogonin). 2% (v/v) glucose was added to the liquid medium every 24h during the fermentation.
Example 4 extraction and identification of fermentation products of recombinant Strain
Culturing the recombinant strain in YPD liquid culture medium to logarithmic phase, and taking 50OD (OD value is Yeast concentration unit, 1OD is about 5x 10)7And (4) yeast cells. OD value was measured by an ultraviolet spectrophotometer at a wavelength of 600 nm), washed twice with sterile water, and transferred to 50mL of YPD liquid medium. The strain for producing baicalein or baicalin does not need to be added with precursor, and the strain for producing wogonin also needs to be added with 200 mu M chrysin. Carrying out fermentation culture at the culture temperature of 30 ℃ and the rotation speed of 200 r/min; culturing the strain for producing baicalein or baicalin for 144 hours, and culturing the strain for producing wogonin for 72 hours; wherein 2% glucose was added every 24 h. 10mL of fermentation liquid after fermentation culture is extracted with equal volume of ethyl acetate for three times. The upper ethyl acetate organic phase was collected, distilled and dissolved in 1mL of methanol for High Performance Liquid Chromatography (HPLC) analysis.
The high performance liquid chromatography analysis is completed by reverse high performance liquid chromatography Agilent 1100, a C18 column is used as a chromatographic column, the column temperature is 30 ℃, the ultraviolet detection wavelength is 275nm, and the elution conditions are shown in Table 3.
TABLE 3 HPLC mobile phase conditions for the target product
Figure BDA0003206623420000161
Example 5 cellular Biomass and product yield during fermentation
Fermentation was carried out according to the 250ml Erlenmeyer flask fermentation culture method of example 3. Sampling is carried out at intervals of 24h during the fermentation period, and the cell biomass and the baicalein, baicalin or wogonin product amount are measured.
The fermentation and production conditions of the baicalein-producing strain are shown in FIG. 2A, and the cell biomass of the baicalein-producing strain gradually increases with the increase of the fermentation time, and the yield of the baicalein also gradually increases, reaches the highest value at about 144 hours of fermentation, and is about 35 mg/L. The method is the highest yield of the baicalein synthesized by whole cells from the beginning at present, and the production requirement can be met only by a basic carbon source glucose without additionally adding phenylalanine as a precursor during fermentation.
The fermentation and production conditions of the baicalin-producing strain are shown in FIG. 2B, and the cell biomass of the baicalin-producing strain gradually increases along with the increase of the fermentation time, and the yield of the baicalin also gradually increases, reaches the highest value at about 144 hours of fermentation, and is about 13 mg/L. The method is the highest yield of the baicalin synthesized by whole cells from the beginning at present, and the production requirement can be met only by a basic carbon source glucose without additionally adding phenylalanine as a precursor during fermentation.
The fermentation and production of the strain producing wogonin are shown in FIG. 2C, and the cell biomass of the strain producing wogonin gradually increased with the increase of fermentation time, and the production of wogonin also gradually increased, reaching the maximum value at about 72 hours of fermentation, and the yield was about 0.55 mg/L.
All documents referred to herein are incorporated by reference into this application as if each were individually incorporated by reference. Furthermore, it should be understood that various changes or modifications of the present invention may be made by those skilled in the art after reading the above teachings of the present invention, and such equivalents may also fall within the scope of the appended claims of the present application.
Sequence listing
<110> university of eastern China's science and technology, Shanghai Chenshan vegetable garden
<120> genetic engineering yeast for producing wogonin compounds, construction method and application thereof
<130> 201993F1
<160> 38
<170> SIPOSequenceListing 1.0
<210> 1
<211> 2082
<212> DNA
<213> Rhodotorula toruloides (Rhodotorula toruloides)
<400> 1
atggctccaa ggcctactag tcagagtcaa gctagaactt gtccaaccac ccaagtcacc 60
caagttgaca ttgtcgaaaa aatgttggcc gccccaaccg actctacctt ggagttggac 120
ggatacagtc ttaatcttgg tgatgttgtc agtgccgcca gaaagggtag accagttagg 180
gtcaaggact ctgacgagat cagatctaaa atcgataaat ctgttgagtt tttgagatct 240
cagttgtcta tgagtgtcta cggagttacc actggtttcg gaggttctgc cgataccaga 300
accgaagacg ccatctctct tcagaaggcc ttgcttgagc accagctttg cggagttttg 360
ccttcttctt tcgattcttt tagattgggt aggggacttg agaactcttt gccattggag 420
gtcgttagag gagctatgac cattagagtt aactctttga ctagaggaca ttctgccgtt 480
aggttggtcg tcttggaggc ccttaccaat tttttgaatc acggtatcac cccaatcgtc 540
cctcttaggg gaaccatcag tgcctctggt gacttgtctc cattgtctta tatcgctgcc 600
gccatcagtg gtcacccaga tagtaaggtc cacgtcgtcc acgagggtaa ggaaaagatc 660
ttgtatgcta gggaggccat ggcccttttc aacttggaac cagttgtctt gggacctaag 720
gagggacttg gattggttaa cggaactgct gtttctgcct ctatggctac ccttgctctt 780
cacgatgccc acatgttgtc tcttttgagt caatctttga ccgctatgac cgtcgaggct 840
atggttggtc atgccggatc tttccaccca tttcttcacg acgttaccag acctcaccca 900
actcaaatcg aagtcgctgg aaatattaga aagcttcttg agggtagtag attcgccgtc 960
catcacgagg aggaagtcaa agtcaaggat gacgagggaa tcttgaggca agatagatat 1020
ccacttagga ctagtccaca atggcttggt ccacttgtca gtgatcttat ccacgctcac 1080
gccgtcttga ccattgaggc tggacagtct accaccgata accctcttat tgacgtcgaa 1140
aataagactt ctcatcacgg tggaaacttc caagctgctg ccgttgctaa caccatggaa 1200
aagactagat tgggtttggc tcagatcggt aagcttaact tcacccaatt gaccgagatg 1260
cttaatgccg gaatgaatag aggacttcca tcttgcttgg ccgccgagga cccttctctt 1320
tcttaccatt gcaagggtct tgatattgct gctgccgctt acacctctga gcttggtcac 1380
ttggctaacc cagttaccac ccatgttcaa ccagctgaga tggctaacca agctgtcaac 1440
agtttggcct tgatcagtgc tagaaggacc accgaatcta acgatgtctt gagtcttttg 1500
ttggccactc acttgtactg cgtcttgcaa gctatcgact tgagggccat cgagtttgag 1560
tttaaaaaac aattcggtcc agctatcgtc agtttgatcg accagcactt cggatctgcc 1620
atgaccggat ctaacttgag ggatgagctt gtcgagaagg ttaacaagac cttggccaag 1680
aggttggagc agactaactc ttacgacctt gtcccaagat ggcacgatgc cttcagtttt 1740
gctgctggaa ccgtcgtcga agttcttagt tctacctctc tttctcttgc cgccgtcaat 1800
gcttggaaag tcgccgctgc tgagagtgcc attagtttga ctaggcaagt tagagagacc 1860
ttctggagtg ccgccagtac ttcttctcca gctttgtctt accttagtcc tagaacccag 1920
atcttgtacg ctttcgttag agaggagctt ggagttaaag ccagaagggg tgacgtcttt 1980
cttggtaagc aagaagtcac catcggttct aatgtttcta aaatctatga agctatcaaa 2040
tctggtagaa ttaataatgt ccttttgaag atgcttgctt ga 2082
<210> 2
<211> 1650
<212> DNA
<213> Scutellaria baicalensis (Scutellaria baicalensis Georgi)
<400> 2
atggagactg tagaaaacca cggtgacgtc attttccggt cgaagctccc cgacatatac 60
atccccaagc acctcccatt gcactcttac tgcttcgaaa acatctccga gcacaggacg 120
aagccatgtc tcatcaacgg cgccaccaat gaggtgcaca cctacgagga agtggagctc 180
atctccagga aggtggcggc ggggctgagc cacctcggcc tccaccacgg agacactatc 240
atgatcctcc tccccaactc gccggaattc gtcttcgcct tcctgggcgc ttcctacatc 300
ggcgccgtct ccaccatggc caatcccttt ttcacccccg ccgaggtcat caagcaggcc 360
aaggcctcca acgccaagct catcatcacg caggcatgct acgtcaagaa agtctgggat 420
tacgccgtcg agaacggcgt cagggttatg tgcgtcgact ctccgccgcc ggaggccgcc 480
ggtgagtgcc tggagttctc ccagctgacc tccgccgacg agggcgacat gccggaggtg 540
gagatcaact ccgaggacgt ggtggcgctg ccgtactcct ccggcacgac ggggctgccg 600
aagggcgtga tgctcacgca caaagggctc gtcaccagcg tcgctcagca agttgacggt 660
gagaacccca atctgtacat tcacagcgac gacgtcatac tctgcgtttt gcccttgttt 720
cacatttact ccttaaactc cgttctgctc tgcgggttac gggtcggggc cgccattctg 780
atcatgcaga aattcgacat tgttcccttt ttggagctga ttcagagata caaagttacc 840
attgggccct tcgtgccgcc cattgttttg gcaattgtga agagccccgt ggtgggcaat 900
tacgaccttt catctatacg gacggtgatg tccggcgcgg cgccgctcgg gaaggagctg 960
gaggaggctg tcagaattaa gtttccgaat gccaaacttg gccagggata tggaatgaca 1020
gaagcagggc cagtgctagc gatgtgtttg gcattcgcaa aagaagggtt cgagataaaa 1080
tcaggtgcat gcgggaccgt cgtaagaaac gctgagatga aaatcgtcga catagaaact 1140
gctgcctcac ttggacgcaa tcaacccggc gagatttgca tcagaggaga tcagatcatg 1200
aaaggctatt tgaatgatcc ggaatcaaca gcaaggacaa tagataaaga agggtggcta 1260
cacacaggtg acatagggtt cattgatgat gatgatgagc tctttattgt tgatcgtctc 1320
aaggaaataa tcaagtacaa agggttccaa gttgctccgg ccgaaatcga ggccctcctc 1380
ctcaatcacc cctccatttc cgatgccgcc gtggtctcaa tgaaagatga agaagcagga 1440
gaagttcctg ttgcctttgt tgtgaaatca aatgggtcca ccataactga ggatgatatc 1500
aagcaattta tatccaaaca ggtgattttc tacaagagaa tacatcgtgt atttttcatt 1560
gatgccattc caaagaatcc atcaggcaaa atattgagaa aggatttgag ggcaatatta 1620
cccacaaaag cagctactct ttcaaattga 1650
<210> 3
<211> 1173
<212> DNA
<213> Scutellaria baicalensis (Scutellaria baicalensis Georgi)
<400> 3
atggtgacag ttgaagaatt ccaccgggca acacgggcag agggccccgc caccgtcttg 60
gccatcggca cggccaaccc cccaaactgc gttgagcagt ctacttatgc tgattactac 120
tttcgcattt gtaaaagtga acacttgact gatcttaaaa agaagtttag ccgcatgtgc 180
gaaaagtctg gcatcaagaa acgttacatg catttaacgg aggagtttct gaaggagaac 240
gacaacttca cggcgtacga ggctccgtca ctggatgccc ggcaggacat agtggtggtg 300
gagatcccga agctggggaa ggaggctgcc cagaaggcga tcaaggaatg ggggcagccc 360
aagtccaaga tcacccacgt catcttctgc actaccagcg gcgtcgacat gcccggcgca 420
gactaccaga tcaccaagct cctcggcctc cgcccctccg tcaagcgctt catgatgtac 480
cagcagggct gcttcgccgg cggcacggtg ctccgcatgg ccaaggacct ggctgagaac 540
aacgccggag ctagggttct tgtcgtctgc tccgagatca ccgccatcac tttccggggg 600
cccagcgaca cccacctcga cagcctggtc ggccaggccc tgttcggcga cggcgccggg 660
gcggtcatcg ttggatccga ccccatcgtg ggggtggagc ggccgctctt ccagctggtc 720
tcggcggcgc agacgattct ccctgacagt gagggcgcca ttgacggcca cgtccgcgag 780
gtcgggctga ccttccacct cctcaaggac gtccccgggc tgatctccaa gaacatcgag 840
aagagcctca aggaggcctt cgcgccgctg ggcatctccg actggaactc cctcttctgg 900
atcgtgcacc ccggaggtcc cgccattctc gaccaggtgg aggagaagct cgggctcaag 960
cccgagatca tggtcccaac caggcacgtg cttagcgaat acgggaacat gtccagcgcc 1020
tgcgttctct tcgtgatgga tgagatgagg aaggcctccg ccaaggacgg ctgcaccacc 1080
accggagaag ggaaggactg gggggttctt ttcggcttcg gcccgggcct caccgttgag 1140
actgtagttc tgcatagtgt gcctctcaat tga 1173
<210> 4
<211> 648
<212> DNA
<213> Scutellaria baicalensis (Scutellaria baicalensis Georgi)
<400> 4
atgtctgctt cgccatccgt caccaaagtc ctagtcgaat ccatcgagtt ctcgccggcc 60
gcaaagccgc cgggatcctc caacacctta ttcctcggcg gcgccggggt gagaggaatg 120
gagatccagg ggaacttcgt gaagttcacg gcgatcggtg tttacttgga agacagcgcc 180
gttccgtctc tcgccgttaa ctggaagggc aagaccgccg aggagttgac ggagtcagac 240
gactttttca gggaaatcgt gtctggtcct ttcgagaaat tcaccaaggt gacgatgatt 300
ctgccattga cggggaagca atactcggag aaagttgcag agaactgcgt tgcgtactgg 360
aaagccgtag ggaaatacac ggatgctgaa tcggaagcaa tcgacaagtt tctccaagtg 420
ttcaaggacg aaacgttcgc gcctggagct tccatcctct tcacccaatc gccggccggc 480
tccttgacga ttagcttctc gaaagacgga tcgattccag agcaagggaa ggcagtaata 540
gagaacaaac agctgtcgga ggcagtgctg gagtcgatca tcggaaagca tggtgtgtcg 600
ccgtcggcga agcagagttt ggcggcaaga ctatcggagt tgttttaa 648
<210> 5
<211> 1509
<212> DNA
<213> Scutellaria baicalensis (Scutellaria baicalensis Georgi)
<400> 5
atggacttag tagaagtcac actctacgcc gccctcttcc tcctctccgc cgccttcctc 60
ctcctaatct tcgccggaga ccgctcctcc ccaccgggcc cgttccctct tccgatcatc 120
gggcacctcc acctcctcgg cccgaaactc caccaaagct tccacgggct gtcccaacgg 180
cacggcccgc tgatgcaaat ccggctgggc tccatcaact gcgtggtggc gtcgacgccg 240
gagctggcta aagagttcct caaaaccaac gagctggtgt tctcctcgcg caaacactcg 300
accgccattg atatcgtcac ctacaattcc tccttcgcct tctccccata cgggccctac 360
tggaagtaca tcaagaagct ctgcacctac gagctgctcg gagcgagaaa cctccaccat 420
ttccagccca tcaggacctt cgaggtccac acttttctcc ggcttctcat ggagaagagc 480
gaatccgggg agagctttaa tgtcaccgag gagctcatta agctcaccag caacgtcatg 540
tccaatatga tgctcggcac caggtgctcc gccacagacg gcgaggcgga ggcggctagg 600
acggtgatcc gggaggtgac ggagatcttc ggggagttcg atgctgctga tatcatctgg 660
ttctgtaaga acttcgattt gcagggaata aggaagaggt cggaggatat tcagagaagg 720
tatgatgctt tgctggaaaa gattatcacc gacagagaga agctccggcg gagccaccgc 780
ggcggcgagg ccaaggattt tcttgatatc tttctggata taatggacag tggcaactct 840
gaggtgaaat tcagcagaga acatctcaaa gctttgattt tggatttctt caccgctggt 900
acagacacaa cggcgatcag cacagagtgg gcaatagcag aactgatgaa caacccaaag 960
gtactaaaga aagcacaaga agagatccag aaagtggtgg gatcttgtag attgatggat 1020
gaatcagacg cccctaatct cccatacctt gaggccatca tcaaggagac cttcaggctc 1080
caccctccga tcccgatgct tgcccggaaa tccgtctccg attgcgtcat cgacggctac 1140
aacatcccgg cgagcactct cctcttcgtc aacatttggt ccattggtcg gaaccccgag 1200
tgttgggaca gccccttctc cttccggccc gaacgcttct tcgagaagga caacgcttcg 1260
atcgatatca aggggcagca cttccagctg ctgccttttg gaacgggcag gaggggctgc 1320
ccgggaatgc ttttggccat acaggagctg ctacttatca taggcactat gattcagtgc 1380
tttgattggg aattgcctga gggttcgggc cctgtcgaca tgaccgaacg ggccgggttg 1440
actgctccac gggctgaaga tttgatttgt cgggtctcct gccgggttga cccgaaaatt 1500
gttttctag 1509
<210> 6
<211> 1554
<212> DNA
<213> Scutellaria baicalensis (Scutellaria baicalensis Georgi)
<400> 6
atggagttga gctctgtcat ctatggcgcc atcgccttgc tctctctttt ctactgttac 60
ctacacttct ccaagccaaa aaagagttcc ctgaacgcgc cgccggaggc tggcggcgcg 120
cgcttcatca ccggccacct ccacctgatg gacggccgct ccgcctccga caaacttcct 180
cacataaacc tgggtttgct tgcagaccag cacggcccaa tcttcacgat caggctgggc 240
gtgcaccgag ccgtggtggt gagcagctgg gagctagcca aggagatctt caccacccac 300
gacacggcgg tcatggctcg gccccggctc atagccgacg actacctgag ctacgacgga 360
gcctcgcttg ggttctcacc ctacggacca tactggcgcg aaatccgcaa gctggtcacc 420
accgagctgc tctcggctcg ccggatcgag ctgcagcgag ccacgcgtgt gcgtgagatc 480
acgcagttca ccggcgagct ctacaagctg tgggaggaga agaaagacgg gtctgggagg 540
gttttggtgg acatgaagca gtggctgggg aacttgagcc tcaatctggt gtcgaggatg 600
gtggtgggca agaggttcta cggcggcgac gactcggaga cgaccaagag gtggcggggc 660
gtcatgaggg agttcttcca gctcatcgga cagttcatcc ccggcgacgg gcttccgttt 720
ctccggtggc tcgacttggg tgggttcgag aagaggacga gggacactgc ctatgagctg 780
gataagatca tcgcaatgtg gctggcggag tatcggaaaa gggaatattc cggcgacgac 840
aaggagcagt gcttcatggc cctcatgctc tcactcgtgc aagctaatcc cactctgcaa 900
ctccactacg atgctgatac catcatcaaa gctacttgcc aggttttgat atcggcggca 960
agtgacacga cgacggtgat cctaatctgg gtaatttccc tcctactaaa caatgctgat 1020
gtcctaaaaa aggttcaaga agaactggac gaacaagtgg ggagagaaag acgagtggaa 1080
gaatcggaca taagcaattt accctacctc caagcggtgg tgaaggagac aatgaggcta 1140
taccctccgg cccccttcgc cggagtacga gccttcagcg aagactgcac cgtgggaggc 1200
taccacatcc agaaaggcac gtttttgata gtcaatctgt ggaagctgca tcgagaccct 1260
cgtgtgtggt ccgatgatgc cttggagttc aaaccacaac ggttttttga caaaaaggtg 1320
gaggttaagg gtcaggactt cgagttgatg ccatttggtg gtggtcgaag aatgtgtccc 1380
ggctcgaacc tgggcatgca catggtgcac tttgtgctgg ctaacatatt gcaggccttt 1440
gacataacca ctgggtccac tgtggatatg accgagagtg ttgggttgac caacatgaaa 1500
gccacaccac ttgatgctat tctcactcca aggttgtcac ctactctata ttaa 1554
<210> 7
<211> 2079
<212> DNA
<213> Arabidopsis thaliana (Arabidopsis thaliana)
<400> 7
atgacctctg ccttgtacgc ctctgatctt tttaagcaat tgaagtctat catgggaact 60
gactctctta gtgacgatgt cgtccttgtc atcgccacta cctctcttgc tcttgttgcc 120
ggtttcgtcg tcttgctttg gaaaaagacc actgccgaca gatctggaga acttaagcct 180
ttgatgatcc ctaagtcttt gatggccaag gatgaggatg acgaccttga ccttggttct 240
ggaaagacta gagtttctat cttcttcgga actcaaactg gaactgctga aggattcgcc 300
aaggcccttt ctgaagagat caaggctaga tacgagaagg ctgccgtcaa ggtcatcgac 360
cttgacgatt acgccgctga tgatgaccag tatgaagaga agcttaagaa ggagactctt 420
gccttttttt gcgtcgctac ctacggtgac ggtgaaccaa ccgacaacgc tgctagattt 480
tctaagtggt ttaccgagga aaatgaaaga gacatcaaac ttcagcagtt ggcctacgga 540
gtctttgcct tgggtaatag acagtacgag cattttaaca agattggtat tgtccttgat 600
gaagaacttt gtaagaaagg tgccaagagg cttattgagg ttggattggg tgacgacgac 660
cagagtatcg aagacgactt taacgcttgg aaggagtctc tttggtctga gcttgacaag 720
cttcttaagg acgaggacga caagtctgtc gccaccccat ataccgctgt cattccagaa 780
tatagagtcg tcacccacga tccaaggttc actactcaga aatctatgga atctaatgtt 840
gctaatggaa acaccaccat tgacatccac catccatgca gagtcgatgt cgccgtccaa 900
aaagagttgc acacccatga gagtgataga tcttgcattc acttggagtt cgacatctct 960
aggaccggta tcacctatga gaccggtgat cacgtcggag tttacgccga gaaccacgtc 1020
gaaatcgtcg aggaagccgg aaagttgttg ggacatagtc ttgatttggt tttttctatt 1080
cacgctgata aggaagacgg atctccattg gagagtgctg tccctccacc tttccccgga 1140
ccatgtacct tgggaaccgg tcttgccaga tacgccgacc ttttgaaccc accaaggaag 1200
tctgctttgg tcgctttggc tgcttacgct accgagccaa gtgaagccga gaagcttaaa 1260
cacttgacca gtccagatgg taaggacgaa tactctcagt ggattgtcgc ctctcagagg 1320
agtttgcttg aagtcatggc cgcctttcct agtgctaagc ctcctcttgg tgtctttttc 1380
gccgctatcg ccccaagatt gcagccaagg tactatagta tcagttcttg ccaagattgg 1440
gccccatcta gggttcatgt caccagtgcc cttgtctatg gaccaactcc aactggtagg 1500
attcacaagg gtgtctgcag tacttggatg aagaacgctg ttccagccga aaagtctcac 1560
gagtgttctg gtgcccctat cttcatcaga gctagtaatt ttaaattgcc ttctaaccca 1620
tctaccccta tcgtcatggt tggtcccgga actggtcttg ccccttttag aggttttttg 1680
caagaaagga tggcccttaa agaggacggt gaggagcttg gttcttctct tcttttcttt 1740
ggttgcagaa atagacaaat ggattttatt tatgaagatg aattgaacaa cttcgtcgac 1800
caaggagtca tctctgagct tattatggct ttctctaggg agggagccca gaaagaatac 1860
gttcagcata agatgatgga gaaagccgcc caagtctggg atcttatcaa agaggaggga 1920
tacttgtatg tctgtggaga cgctaaggga atggctaggg acgtccatag aacccttcac 1980
actatcgtcc aagaacaaga gggagttagt agttctgagg ccgaagccat cgtcaagaag 2040
ttgcaaaccg agggtaggta tcttagggac gtttggtga 2079
<210> 8
<211> 1431
<212> DNA
<213> Scutellaria baicalensis (Scutellaria baicalensis Georgi)
<400> 8
atgggtcagc ttcacattgt ccttgtccct atgatcgccc acggtcacat gatccctatg 60
ttggacatgg ctaaactttt tagttctagg ggtgttaaga ccaccatcat cgctactcca 120
gccttcgctg aaccaattag aaaagctagg gagagtggtc acgacatcgg attgaccacc 180
accaagttcc cacctaaggg atctagtctt ccagataata ttagaagttt ggaccaagtt 240
accgacgact tgttgcctca cttctttaga gctcttgagt tgttgcaaga accagtcgag 300
gagattatgg aggacttgaa gccagattgc ttggtcagtg acatgttcct tccatggacc 360
accgacagtg ccgctaagtt cggtatccca agattgcttt tccacggaac cagtcttttc 420
gctaggtgct ttgccgagca gatgagtatc cagaagcctt ataagaatgt cagttctgac 480
tctgagccat tcgtccttag aggtttgcca cacgaggtct ctttcgtcag aacccagatt 540
ccagactacg aattgcaaga gggaggagac gacgccttct ctaagatggc caaacagatg 600
agggacgccg acaagaagag ttatggtgac gttatcaact cttttgaaga attggagtct 660
gaatacgctg actataataa aaatgtcttc ggaaagaaag cttggcacat cggtcctctt 720
aagttgttca acaatagagc tgagcagaag tcttctcaga ggggtaagga gagtgccatc 780
gatgaccacg agtgccttgc ttggcttaac tctaagaagc caaattctgt cgtttacatg 840
tgcttcggaa gtatggccac cttcactcca gctcaacttc acgagaccgc tgtcggactt 900
gagagtagtg gtcaagattt catctgggtc gtcagaaacg gtggtgagaa tgaggactgg 960
ttgccacaag gattcgagga gagaatcaaa ggtaagggac ttatgattag gggttgggct 1020
ccacaagtta tgatcttgga ccacccaagt accggtgctt tcgtcaccca ctgcggatgg 1080
aactctacct tggagggtat ctgcgccgga cttccaatgg tcacttggcc agtctttgct 1140
gagcagttct ataatgagaa gcttgtcacc gaagtcctta agaccggagt ctctgtcggt 1200
aacaagaagt ggcaaagggt cggagaagga gtcggaagtg aagccgttaa ggaggccgtt 1260
gagagagtca tggttggaga tggagccgcc gaaatgagaa gtagggcctt gtactacaag 1320
gaaatggcta gaaaagccgt cgaggaggga ggaagttctt acaataacct taacgctttg 1380
atcgaagagt tgagtgccta cgtccctcct atgaaacaag gattgaattg a 1431
<210> 9
<211> 1581
<212> DNA
<213> Scutellaria baicalensis (Scutellaria baicalensis Georgi)
<400> 9
atgctatatg acaacagcca atacttagcc atggaattca gttctgccat ttatggagcc 60
attgccttct ttcttttctt atactattgc ctgctctata caacatcttc caagccaaat 120
accagagctt acaaagcacc gccggaggct ggcggggcgc gcctcttttc cggccatctc 180
catctcatgg ctggtggcac caccggtgaa cttccccaca tcaacttggc taacttagca 240
gataaacacg gcccagtttt cacaatccgg ctgggcgtaa agcgagcctt ggtggtgagc 300
agttgggaat cagccaaaga actgttcact acctgtgacg tggcggtgtc gtcccgtcca 360
cgtatgaagg cggcgaagct cttaggctat gatttcgcca tgtttgggtt cgccccatac 420
ggtgcatact ggcgtgagct gcgaaaactg atctcagttg agcttctctc aactcgtaga 480
atggagttgc agaaagaggt tcgagattca gaaactaggg agtccattaa agagctttat 540
aagctttggg aagagagaag tgagggttcg gacagtgtgt tggtggacat gaagcagtgg 600
tttggggact tgaacttgaa tgttgtcctg agaatggtgg cggggaagag atggatcggc 660
ccggagacgg ggcggtggag ggaggtgctg agggatttct tctacttggc ggggatgttt 720
gttccggccg atgcctttcc gtttcttggg tggttggatt taggcggaca tgagaagaga 780
atgaggcaaa ctgctaaaga attggacgga attgttggag gatgggtggc ggagcatcgg 840
gaaaaggaat attccggcga agataagcca aaggatttcg tcgatgttat gttgtctgtt 900
gtacaaggtt caagtcttcg agctgactat gatgctgata ccatcatcaa agcaacatgc 960
gaggctttga ttgtgggtgg aagtgacact acaacagtga tgctaatatg gacactttct 1020
ttcctattga ataatcggca tgttctgaga aaggctcaag aagagctgga caagcatgta 1080
ggaagggaaa gacgtgtaaa ccaatcagac atcaacaact tagtctatct tcaggcaata 1140
gttaaagaga ctttgagatt ataccctgct ggccccattg gtgggatacg agagttcacc 1200
caagattgcc aagtcggagg ctaccacgtt cctaaaggca cgtggctgat cgtgaacttg 1260
tggaagttgc atcgagatcc caaggtttgg tcagaagatt gtttggaatt taggccagaa 1320
cgatttctaa ataaaaacat agatgtcagg ggtcaagatt tcgagttgat cccatttggt 1380
ggtggtcgga ggatttgccc cggggctaat tttgggctgc atatgctgca tttggtgttg 1440
gctaacttgc tgcaagcttt cgagctcacc actgtgtccg atcaagtgat tgatatgacg 1500
gagagtgctg gaatgacaaa tatgaaagcc acaccactta atgttcttgt tgccccaagg 1560
ttgtctccca ctctttactg a 1581
<210> 10
<211> 705
<212> DNA
<213> Scutellaria baicalensis (Scutellaria baicalensis Georgi)
<400> 10
atgatcgaga agtacaaccg caccattctc cagagcgaca ctctcctcaa gtacattttg 60
gaaacgagtg cctttcccag agaacatgaa cagcttaagg agctgagaga agctactgtt 120
gaaaagtaca aagcttggag tttgatgaat gtgcctgctg atgaggggca gtttatttcg 180
atgcttttga aaataatgaa tgcaaagaag acaattgaaa ttggggtttt cactggatac 240
tcacttctct ctacagctct tgctcttcct catgatggca aaataatagc aattgatcca 300
gacaaagaag catatgagac tggtctgccc agcattcaga aggccaacat ggctcacaaa 360
attcacttct tcgattctcc tgccacacaa atcttggatg atctcatcgc caagggagaa 420
gaaggcacgt tcgattttgc atttgtggat gcagacaaag aaaactacat gaattatcac 480
gagcaattat tgaaactggt taagattggg ggagtgatcg ggtacgacaa caccctatgg 540
ttcggtacgg tggcatcgcc tgagacggag gagatgttgg agtttgtgaa gagtagtcga 600
gcccatatgg tggagttgaa ctcttttctt gcaaccgatt ctcgtatcga gttagcccat 660
ctttctatcg gagatggact tgctttgtgc aagcgtctca aatga 705
<210> 11
<211> 40
<212> DNA
<213> primers (Primer)
<400> 11
tcaattgaac aactatttcg atggagactg tagaaaacca 40
<210> 12
<211> 40
<212> DNA
<213> primers (Primer)
<400> 12
gccgccgcgg ctcgaggtac atttgaaaga gtagctgctt 40
<210> 13
<211> 40
<212> DNA
<213> primers (Primer)
<400> 13
tcaattgaac aactatttcg atggtgacag ttgaagaatt 40
<210> 14
<211> 40
<212> DNA
<213> primers (Primer)
<400> 14
gccgccgcgg ctcgaggtac attgagaggc acactatgca 40
<210> 15
<211> 39
<212> DNA
<213> primers (Primer)
<400> 15
tcaattgaac aactatttcg atgtctgctt cgccatccg 39
<210> 16
<211> 40
<212> DNA
<213> primers (Primer)
<400> 16
gccgccgcgg ctcgaggtac aaacaactcc gatagtcttg 40
<210> 17
<211> 40
<212> DNA
<213> primers (Primer)
<400> 17
tcaattgaac aactatttcg atggacttag tagaagtcac 40
<210> 18
<211> 40
<212> DNA
<213> primers (Primer)
<400> 18
gccgccgcgg ctcgaggtac gaaaacaatt ttcgggtcaa 40
<210> 19
<211> 40
<212> DNA
<213> primers (Primer)
<400> 19
tcaattgaac aactatttcg atggagttga gctctgtcat 40
<210> 20
<211> 40
<212> DNA
<213> primers (Primer)
<400> 20
gccgccgcgg ctcgaggtac atatagagta ggtgacaacc 40
<210> 21
<211> 40
<212> DNA
<213> primers (Primer)
<400> 21
tcaattgaac aactatttcg atgctatatg acaacagcca 40
<210> 22
<211> 40
<212> DNA
<213> primers (Primer)
<400> 22
gccgccgcgg ctcgaggtac gtaaagagtg ggagacaacc 40
<210> 23
<211> 40
<212> DNA
<213> primers (Primer)
<400> 23
tcaattgaac aactatttcg atgatcgaga agtacaaccg 40
<210> 24
<211> 40
<212> DNA
<213> primers (Primer)
<400> 24
gccgccgcgg ctcgaggtac tttgagacgc ttgcacaaag 40
<210> 25
<211> 42
<212> DNA
<213> primers (Primer)
<400> 25
gaccttcgtt tgtgcggatc agatcttttt tgtagaaatg tc 42
<210> 26
<211> 40
<212> DNA
<213> primers (Primer)
<400> 26
gctatggtgt gtgggggatc tctcacttaa tcttctgtac 40
<210> 27
<211> 40
<212> DNA
<213> primers (Primer)
<400> 27
ttactcttcc agattttctc agatcttttt tgtagaaatg 40
<210> 28
<211> 40
<212> DNA
<213> primers (Primer)
<400> 28
gcgatgcgcg gagtccgaga tctcacttaa tcttctgtac 40
<210> 29
<211> 40
<212> DNA
<213> primers (Primer)
<400> 29
ggcagtaatt gatatactag attttggtca tgcatgagat 40
<210> 30
<211> 40
<212> DNA
<213> primers (Primer)
<400> 30
gacctaccct acgacgggcc ttgaagctat ggtgtgtggg 40
<210> 31
<211> 40
<212> DNA
<213> primers (Primer)
<400> 31
taagggattt tggtcatgca aaagagtgag aggaaagtac 40
<210> 32
<211> 40
<212> DNA
<213> primers (Primer)
<400> 32
aaaagatctg atctcatgca caaaagcctg ctagatgtgc 40
<210> 33
<211> 23
<212> DNA
<213> primers (Primer)
<400> 33
ggggtgagcc tcaaggtata tag 23
<210> 34
<211> 21
<212> DNA
<213> primers (Primer)
<400> 34
gggatagcca tcgtttcgaa t 21
<210> 35
<211> 27
<212> DNA
<213> primers (Primer)
<400> 35
ctatgaccat gattacgaat tcgagct 27
<210> 36
<211> 20
<212> DNA
<213> primers (Primer)
<400> 36
tgcctgcagg tcgactctag 20
<210> 37
<211> 20
<212> DNA
<213> primers (Primer)
<400> 37
catgattacg aattcgagct 20
<210> 38
<211> 20
<212> DNA
<213> primers (Primer)
<400> 38
gtcgactcta gacggactca 20

Claims (10)

1. A method of producing wogonin, comprising:
(1) providing a yeast engineering bacterium, wherein an exogenous expression cassette of the following genes is transformed in the yeast engineering bacterium: F8H, PFOMT 5; and
(2) culturing the yeast engineering bacteria in the step (1), and adding chrysin as a precursor to produce wogonin.
2. The method of claim 1, wherein the F8H and/or PFOMT5 is from Scutellaria baicalensis (Scutellaria baicalensis Georgi, Sb).
3. The method of claim 1, wherein the engineered yeast is pichia pastoris.
4. The method of claim 3, wherein KU70 gene function is down-regulated or deleted in Pichia pastoris.
5. The method of claim 1, wherein the culturing in step (2) is carried out using a yeast medium, and the carbon source is supplemented during the culturing.
6. The method of claim 5, wherein the carbon source is glucose; more preferably, the glucose is added 1 time every 12 to 36 hours until the final concentration is 1 to 4% (v/v); preferably, during initial culture, chrysin is added into a yeast culture medium, and the final concentration in a fermentation liquid is 50-800 mu M; preferably, the cultivation time in step (2) is 55-95 hours.
7. The yeast engineering bacteria for producing wogonin is characterized by comprising an exogenous expression cassette of the following genes: F8H, PFOMT 5.
8. The engineered yeast strain of claim 7, wherein the engineered yeast strain is Pichia pastoris; preferably, the F8H and/or PFO MT5 is from Scutellaria baicalensis.
9. Use of a combination of genes comprising the following group of genes: F8H and/or PFO MT5, the genome combination is used for transforming into yeast engineering bacteria to prepare wogonin compounds; preferably, the F8H and/or PFO MT5 is from Scutellaria baicalensis.
10. A kit for producing wogonin, comprising: F8H and PFOMT5 genes or expression constructs or yeast cells containing the genes, and chrysin or a culture medium containing the chrysin; preferably, the F8H and/or PFO MT5 is from Scutellaria baicalensis.
CN202110918657.6A 2020-04-07 2020-04-07 Genetic engineering yeast for producing wogonin compounds, and construction method and application thereof Pending CN113621530A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110918657.6A CN113621530A (en) 2020-04-07 2020-04-07 Genetic engineering yeast for producing wogonin compounds, and construction method and application thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010263807.XA CN111440734B (en) 2020-04-07 2020-04-07 Genetic engineering yeast for producing baicalein compounds, and construction method and application thereof
CN202110918657.6A CN113621530A (en) 2020-04-07 2020-04-07 Genetic engineering yeast for producing wogonin compounds, and construction method and application thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN202010263807.XA Division CN111440734B (en) 2020-04-07 2020-04-07 Genetic engineering yeast for producing baicalein compounds, and construction method and application thereof

Publications (1)

Publication Number Publication Date
CN113621530A true CN113621530A (en) 2021-11-09

Family

ID=71648250

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202010263807.XA Active CN111440734B (en) 2020-04-07 2020-04-07 Genetic engineering yeast for producing baicalein compounds, and construction method and application thereof
CN202110918657.6A Pending CN113621530A (en) 2020-04-07 2020-04-07 Genetic engineering yeast for producing wogonin compounds, and construction method and application thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN202010263807.XA Active CN111440734B (en) 2020-04-07 2020-04-07 Genetic engineering yeast for producing baicalein compounds, and construction method and application thereof

Country Status (1)

Country Link
CN (2) CN111440734B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114717170A (en) * 2021-01-05 2022-07-08 中国科学院分子植物科学卓越创新中心 Host cell for heterogeneously synthesizing flavonoid compound and application thereof
CN114774442B (en) * 2022-04-29 2023-10-17 中国科学院天津工业生物技术研究所 Recombinant yarrowia lipolytica for producing scutellarin and construction method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110042112A (en) * 2019-04-23 2019-07-23 上海辰山植物园 Skullcapflavone Phenylpropanoid Glycosides and flavonoids O- methyl transferase gene and its vector construction and application

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10287528A (en) * 1997-04-07 1998-10-27 Rashieru Seiyaku Kk Cosmetic composition
WO2013138523A1 (en) * 2012-03-15 2013-09-19 The Regents Of The University Of California Methods for altering lipids in algae and yeast
US10604782B2 (en) * 2015-07-02 2020-03-31 Kansas State University Research Foundation High-throughput fluorescent screening assay for inhibitors of gram-negative bacterial iron uptake
CN107164253B (en) * 2016-03-15 2020-10-27 中国医学科学院药物研究所 Genetically engineered bacterium for catalyzing glucosidation of flavonoid compound and application thereof
CN109055399B (en) * 2017-06-13 2021-08-20 上海辰山植物园 Gene sequence related to flavone composition in scutellaria baicalensis and application thereof
CN110885846B (en) * 2018-09-07 2023-08-25 中国科学院分子植物科学卓越创新中心 Microorganism for synthesizing baicalein and scutellarin, preparation method and application thereof
CN110079546B (en) * 2019-05-15 2022-10-11 华东理工大学 Multi-gene knock-in method for pichia pastoris expression host
CN110892939A (en) * 2019-12-27 2020-03-20 湖南省微生物研究院 Method for producing baicalein by fermenting bacillus subtilis, feed additive prepared by fermentation and preparation method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110042112A (en) * 2019-04-23 2019-07-23 上海辰山植物园 Skullcapflavone Phenylpropanoid Glycosides and flavonoids O- methyl transferase gene and its vector construction and application

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LIU ET AL.: "CRISPR-Cas9-mediated genomic multiloci integration in Pichia pastoris", MICROB CELL FACT., vol. 21, no. 18, pages 1 - 11 *
QING ZHAO 等: "Two CYP82D Enzymes Function as Flavone Hydroxylases in the Biosynthesis of Root-Specific 4′-Deoxyflavones in Scutellaria baicalensis", MOL PLANT, vol. 11, no. 1, pages 135, XP055689651, DOI: 10.1016/j.molp.2017.08.009 *
方誉民 等: "黄芩属植物黄酮生物合成研究进展", 《中国中药杂志》, pages 1 - 11 *

Also Published As

Publication number Publication date
CN111440734B (en) 2021-08-17
CN111440734A (en) 2020-07-24

Similar Documents

Publication Publication Date Title
CN109055399B (en) Gene sequence related to flavone composition in scutellaria baicalensis and application thereof
CN111440734B (en) Genetic engineering yeast for producing baicalein compounds, and construction method and application thereof
EP4095145A1 (en) New carbon glycoside glycosyltransferase and use thereof
KR101091155B1 (en) Genes which are related to 4-Coumaric acid, caffeic acid and ferulic acid biosynthesis and a method of production using therof
EP3848462A1 (en) Baicalein- and wild baicalein-synthesizing microorganism, preparation method for same, and applications thereof
CN109266630A (en) A kind of lipase and its preparing the application in Bu Waxitan intermediate
CN104726478A (en) Recombinant Escherichia coli for expressing arginine deiminase gene and application of recombinant Escherichia coli
CN114836495A (en) Construction and application of genetic engineering bacteria for producing NMN (N-methyl-N) by utilizing nicotinamide fermentation
KR102473375B1 (en) Recombinant microorganisms, their preparation methods and their use in the production of coenzyme Q10
CN107880134B (en) Method for enzymatic synthesis of kaempferol
CN110305855A (en) Rhizoma Gastrodiae GeCPR gene and its application
CN112795587B (en) Escherichia coli engineering bacteria producing surfactant, construction method and application thereof
KR101190879B1 (en) Recombinant microorganism containning indole oxygenase derived from Corynebacterium and its using method of producing indirubin
CN113005130A (en) Tanshinone IIA synthase gene and application thereof
CN113584110A (en) Construction and application of engineering strain for biosynthesizing mogroside V by taking mogrol as substrate
CN110468091B (en) Microorganism and use thereof
CN107810269A (en) Novel promoter and application thereof
CN106701857B (en) Construction and application of genetic engineering bacteria for producing lovastatin and monacolin J
Lu et al. Heterologous biosynthesis of medicarpin using engineered Saccharomyces cerevisiae
CN110540943A (en) Gene engineering strain for producing emodin and construction method and application thereof
CN114480448B (en) Gene GbF3&#39; H for promoting synthesis of ginkgo flavonol glycosides, and vector, protein and application thereof
WO2023138679A1 (en) Method for regulating and controlling heterologous synthetic flavonoid compound and use thereof
CN112322564B (en) Escherichia coli engineering bacterium and construction method and application thereof
CN113667655B (en) Curculigo orchioides glycosyltransferase Co84A-471 gene and application thereof in preparation of orcinol glucoside
CN117844831A (en) Gene expression cassette, recombinant vector, host strain and application of icariin expressed and synthesized in tobacco

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20211109